10th Annual Forensic Science Symposium - Insights
Mayo Clinic's 10th Annual Forensic Science Symposium will cover a wide variety of topics, ranging from forensic odontology to traffic accident injuries. There will also be a focus on fatal accident prevention, all-terrain vehicle (ATV) use...
10th Annual Forensic Science Symposium - Insights
Mayo Clinic's 10th Annual Forensic Science Symposium will cover a wide variety of topics, ranging from forensic odontology to traffic accident injuries. There will also be a focus on fatal accident prevention, all-terrain vehicle (ATV) use...
hereditary_peripheral_neuropathies_testing_algorithm.pdf
Inherited neuropathy suspected; Insidious onsets progressive (years)* The following tests should be performed in all adult patients: HbA1c or glucose tolerance, vitamin B12, monoclonal proteins. Order PMPDD / PMP22 Gene, Large Deletion...
helicobacter_pylori_diagnostic_algorithm.pdf
≥60 years old; OR Alarming signs and symptoms: ■ Family history of proximal gastrointestinal cancer ■ Previous malignancy of the esophagus or stomach ■ Unexplained iron-deficiency anemia ■ Palpable mass or lymphadenopathy ■ Melena ■...
Cytology: A compelling molecular testing approach - Insights
Learn more about how Mayo Clinic Laboratories is advancing the use of cytology specimens for solid tumor next-generation sequencing.
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...